Tag: NWBO

Blue Horseshoe Stocks: CBGI Update, Form-4 Scan & More

Cannabusiness Group, Inc. CBGI

After adding CBGI to our radar on Monday, (At a low of .0321), and putting the stock on high alert yesterday, we’ve managed to do very well with this new player in the medical marijuana game. If you recall, yesterday, we sounded the alarm on CBGI in our pre-market report, putting it on “high alert” after receiving news that the company had acquired a plot of land in California to commence its plans for a licensed cannabis grow operation. In addition, we pointed out the Golden Cross that was forming on the chart as another reason why CBGI was in a prime position to blow its top.

That’s exactly what took place, as the stock opened at .045, dipped briefly to .041, and the it was off to the races. We saw CBGI run 217% to .13, which also marked an overall gain of 305% from Monday’s low. Following that initial rip, the stock would pull back and bounce several times for added intraday opportunities, and landed us at the top of the Penny Stock Rumble:

Congratulations to anyone who was able to take advantage of the chance for quick-strike profits!

CBGI ended the day at .076 up over 120% from its previous close, and we’d like to see support hold in the .06-.07 range in order for this play to retain our interest. We are still on the cusp of seeing that Golden Cross, so we’ll be keeping an eye on CBGI through to next week, when it looks like that might occur.

Extended Watchlist Winners:

Pixelworks, Inc. PXLW

We’ve got to take a minute to applaud ourselves for another of yesterday’s selections. PXLW appeared in our Extended Watchlist and went on to have a beast of a day. The stock shot up from 6.31 to 9.05, a solid 43% increase, and did so on more than 30x  its 3-month average volume.

Fanny & Freddie (FNMA & FMCC)

Also making several appearances in our recent reports, we like the gains we’ve seen from this mortgage-lending pair. Both stocks have recently come from the $3.00-range and are now trading well over $5.00.

Form-4 Scan

Our regulars know that we periodically like to conduct Form-4 (Insider Trading) Scans, and have gleaned some big winners by doing so in the past (e.g. CETV made a 147% move for us). As a result of the one we ran this morning, we have a couple of stocks we’d like to throw into the mix:

Biodel, Inc. BIOD

BIOD popped up after several company officers filed their form-4’s which denote an exercise price of 3.37 (Currently trading in the mid-3.40’s), so we’ll be placing this one on our radar for sure. For our readers who may not be as well-versed, let us explain the significance. While Form-4’s reflecting the acquisition of shares by insiders shouldn’t be taken as a definite sign of something big brewing behind the scenes, it does suggest a certain in-house confidence in the stability of a stock that we like to see. It never hurts to put a stock on watch just in case there is something bigger going on.

Career Education Corp. CECO

The other one we spotted on this scan was CECO. A good number of Form-4’s have been submitted over the course of this week, so we’ll be throwing this one up on our radar sceens as well.

Side Note:

MLCG and MDCN are a couple of longer-term marijuana stocks that we think folks should have on their watchlists.

Extended Watchlist:
BMSN, FCEL, SKUL, NWBO, HART, CCRN, PLUG BSPM,

ERBB, AEGY, BDSI & Extended Watchlist

Tranzbyte Corp. ERBB
–
We highlighted ERBB on Friday and the stock came out swinging, continuing the momentum that was building in the previous session.It came out of the gate strong, running quickly from a low of .0119 up as high as .0154. That marks a respectable intraday move of 29%As the stock pulls back off of that run, we’d like to see support hold over a penny, and will be monitoring the situation for any possible bounce opportunities.

Alternative Energy Partners, Inc. AEGY

We’ve had AEGY on our radar since last spring, and after a serious increase in recent trading activity, we wanted to bring it back into the conversation. The stock has been in full-on breakout mode for the past couple of sessions, and appears to want to gap up even further this morning.  What we are going to want to do is watch carefully for any possible dip-and-rip opportunities. Stocks that gain so much ground over so short a time-frame are susceptible to high volatility and sudden pullbacks, and are often followed by what can be very lucrative bounceplays for quick-witted traders.

This is another of the medical marijuana related stocks that we’ve been tracking for a long while. AEGY, in particular, operates pharmajanes.com an online dispensary for California residents, but the list of companies that we’ve tracked cover every part of the sector, from medical to legal cannabis, to growing apparatus, and more.

To list a few of the standouts we’ve tracked over an extended time: EAPH, FITX, CBIS, HEMP, PHOT, MJNA, SKTO, TRTC, EDXC, MWIPD, EXMT, CANN, MDBX, GWPH and that’s only a partial list. Cannabis has been allowing a lot of people to cash in via the stock market, and we expect the opportunities to keep coming.

BioDelivery Sciences International, Inc. BDSI
–
BDSI appeared in Friday’s Extended Watchlist and made a notable 16% intraday move, trading from a low of 8.18 to 9.49 on almost 15M shares traded. The spike in price and volume comes on the heels of Thursday’s PR regarding positive testing results for the pain medication the company has under development:
–

Extended Watchlist:
REVI, RITT, NWBO, MM, ALU, CLSN, HIHO, RNN

TGRO, WMIH, BGMD, ZGNX, NAVB & Extended Watchlist

Tiger Oil & Energy, Inc. TGRO
–
For those of you who may have missed yesterday’s morning and afternoon reports on TGRO, the stock had a marquee day, putting up one of the best performances in the whole of the OTC Markets.

On more than 20x the 3mo. average volume, TGRO bulled its way upward throughout the day, starting at a low of .36 and reaching as high as .524, good for a strong intraday move and chance for up to a 46% profit. A strong close at .52 effectively puts us on the lookout for continued momentum this morning, though as always, traders should use caution on a stock that has seen such rapid increases.

Our timely mention of TGRO (coming just a day after the stock woke up from the dead) also put us at the top of Monday’s Penny Stock Rumble:

WMI Holdings Corp. WMIH

WMIH appeared on our Blue Horseshoe Stocks blog with yesterday afternoon’s alert, at which time the stock was trading in the 1.42 area. It would go on to experience a 27% move to 1.81 in the final hours of the session.

WMIH is now heading into uncharted territory, being the highest it’s ever been. We are going to be cautious for a pullback, and in that event we’d like to see the previous resistance, our alert price of 1.42, hold as support.

SEATTLE, Dec. 9, 2013 /PRNewswire/ — WMI Holdings Corp. (WMIH) (“WMI” or the “Company”) today announced that KKR & Co. L.P. has entered into a conditional commitment letter to make a strategic investment in the Company (the “Commitment Letter”), dated December 8, 2013. >>>Read Release

BG Medicine, Inc. BGMD

We’ve also got a new item for your tickers this morning. BGMD has news out, and looks set for an interesting session as the stock is gapping up in pre-market trading, coming off of recent lows and breaking above the 50DMA (.64), a recent area of resistance.

We’ll be monitoring BGMD today as it reacts to this morning’s announcement:

WALTHAM, Mass., Dec 10, 2013 (GLOBE NEWSWIRE via COMTEX) — BG Medicine, Inc. (Nasdaq:BGMD) announced today that the Centers for Medicare and Medicaid Services (CMS) have published the final determination of the 2014 Medicare national limitation amount for the Company’s galectin-3 blood test (analyte-specific CPT(R) Code 82777) at the amount of a crosswalked test (analyte-specific CPT(R) Code 84244) whose 2014 national limitation amount is $30.01. This national limitation amount will replace the galectin-3 blood test’s national limitation amount of $17.80 that was effective in 2013.

The following are plays with FDA-related news out this morning that we’ll want to watch closely today:

Zogenix, Inc. ZGNX
FDA Approval News out this morning, monitoring for potential breakout. >>>View PR

Navidea Biopharmaceuticals, Inc. NAVB
FDA has granted “Fast Track” status for the company’s lymph node detection test. >>>View PR

Extended Watchlist:
GERN, ARIA, CNDO, RMBS, VTNC, BLRX, NWBO